NovoCure Limited (NVCR)

NovoCure Revenue

NovoCure had revenue of $154.99M in the quarter ending March 31, 2025, with 11.91% growth. This brings the company's revenue in the last twelve months to $621.71M, up 18.27% year-over-year. In the year 2024, NovoCure had annual revenue of $605.22M with 18.82% growth.

• Revenue (ttm): $621.71M
• Revenue Growth: +18.27%
• P/S Ratio: 3.23
• Revenue / Employee: $417,817
• Employees: 1,488
• Market Cap: 2.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	605.22M	95.88M	18.82%
Dec 31, 2023	509.34M	-28.50M	-5.30%
Dec 31, 2022	537.84M	2.81M	0.53%
Dec 31, 2021	535.03M	40.66M	8.23%
Dec 31, 2020	494.37M	143.05M	40.72%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.